CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma ; volume:13 ; number:1 ; day:12 ; month:6 ; year:2020 ; pages:1-10 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (12.6.2020), 1-10, 12.2020
- Creator
-
Lupo, Kyle B.
Matosevic, Sandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00913-2
- URN
-
urn:nbn:de:101:1-2020081020213720642765
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lupo, Kyle B.
- Matosevic, Sandro
- SpringerLink (Online service)
Other Objects (12)
Natural killer cell immunotherapy in glioblastoma
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Natural killer cell immunotherapy in glioblastoma
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Natural killer cell immunotherapy in glioblastoma
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
MRP3: a molecular target for human glioblastoma multiforme immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art